NCT00848445View on ClinicalTrials.gov

Atrial Fibrillation: Canadian Atrial Fibrillation Evaluation (CAFE) Study -

PHASE4CompletedINTERVENTIONAL
Enrollment

270

Participants

Timeline

Start Date

October 31, 2002

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Atrial Fibrillation
Interventions
DEVICE

Guidant Pulsar Max II or Insignia Plus DR

market approved pacemaker. programmed per protocol

DEVICE

Atrial pacing preference turned on or off

programing changes in the device

Sponsors
All Listed Sponsors
lead

Boston Scientific Corporation

INDUSTRY